Literature DB >> 6432998

Rapid gas chromatographic assay for monitoring valproic acid and valpromide in plasma.

M Bialer, M Friedman, A Rubinstein.   

Abstract

A gas chromatographic (GC) method for monitoring valproic acid and valpromide in plasma was developed. The procedure involved a single solvent extraction of drugs from acidified plasma samples, followed by a GC injection of the organic phase. This rapid, sensitive, specific, and reproducible method is a key factor in pharmacokinetic and stability studies of valpromide. Pharmacokinetic application of the new GC method is presented by a simultaneous plasma monitoring of valpromide and valproic acid levels obtained after intravenous administration of valpromide to a dog.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432998     DOI: 10.1002/jps.2600730734

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  Pharmacokinetic analysis and antiepileptic activity of tetra-methylcyclopropane analogues of valpromide.

Authors:  M Bialer; S Hadad; B Kadry; A Abdul-Hai; A Haj-Yehia; J Sterling; Y Herzig; B Yagen
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

2.  Pharmacokinetics and anticonvulsant activity of three monoesteric prodrugs of valproic acid.

Authors:  K Badir; A Haj-Yehia; T B Vree; E van der Kleijn; M Bialer
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

3.  Pharmacokinetics and antiepileptic activity of valproyl hydroxamic acid derivatives.

Authors:  M Levi; B Yagen; M Bialer
Journal:  Pharm Res       Date:  1997-02       Impact factor: 4.200

Review 4.  Clinical pharmacology of valpromide.

Authors:  M Bialer
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

5.  Structure-pharmacokinetic relationships in a series of valpromide derivatives with antiepileptic activity.

Authors:  A Haj-Yehia; M Bialer
Journal:  Pharm Res       Date:  1989-08       Impact factor: 4.200

6.  Pharmacokinetic analysis of the structural requirements for forming "stable" analogues of valpromide.

Authors:  A Haj-Yehia; S Hadad; M Bialer
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

Review 7.  Can we develop improved derivatives of valproic acid?

Authors:  M Bialer; A Haj-Yehia; K Badir; S Hadad
Journal:  Pharm World Sci       Date:  1994-02-18

8.  Pharmacokinetics of valpromide after oral administration of a solution and a tablet to healthy volunteers.

Authors:  M Bialer; A Rubinstein; I Raz; O Abramsky
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Pharmacokinetic analysis and antiepileptic activity of N-valproyl derivatives of GABA and glycine.

Authors:  S Hadad; M Bialer
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.